FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Central Admixture Pharmacy Services fentaNYL Recall

fentaNYL, 1250 mcg/25 mL, (50 mcg/mL), 30 mL Syringe, Rx only, Central Admixture Pharma…

Central Admixture Pharmacy Services Inc · San Diego, CA

Risk level
Class II
Reported by FDA
Aug 9, 2023
Recall ID
D-1043-2023
Check your lot numberHow we source this data

Summary

Central Admixture Pharmacy Services recalled fentaNYL starting Jul 17, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1043-2023 on Aug 9, 2023. Reason: Lack of assurance of sterility: Lack of validation data for sanitization cycles. Status: Terminated.

Why it was recalled

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Product description

fentaNYL, 1250 mcg/25 mL, (50 mcg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-7

Lot numbers, UPCs & expiration codes

Lot: 17-270664, Exp. 7/18/2023; 17-270886, Exp. 7/20/2023; 17-270976, 17-270989, Exp. 7/23/2023; 17-271335, Exp. 7/27/2023; 17-271572, Exp. 8/1/2023; 17-271747, Exp. 8/3/2023; 17-271808, Exp. 8/6/2023; 17-272023, Exp. 8/9/2023; 17-272203, Exp. 8/13/2023; 17-272718, Exp. 8/21/2023; 17-272797, Exp. 8/22/2023; 17-273157, Exp. 8/29/2023; 17-273507, Exp. 9/4/2023; 17-273766, Exp. 9/7/2023; 17-273862, Exp. 9/10/2023; 17-274052, Exp. 9/12/2023; 17-274208, Exp. 9/14/2023.

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1043-2023
Classification
Class II
Status
Terminated
Recall initiated
Jul 17, 2023
FDA report date
Aug 9, 2023
Quantity
5,124 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
Central Admixture Pharmacy Services Inc

Original FDA data

Every field from FDA enforcement report D-1043-2023, exactly as published.

Show all FDA fields
City
San Diego
State
CA
Status
Terminated
Country
United States
Event ID
92752
Address
7935 Dunbrook Rd Ste C
Code information
Lot: 17-270664, Exp. 7/18/2023; 17-270886, Exp. 7/20/2023; 17-270976, 17-270989, Exp. 7/23/2023; 17-271335, Exp. 7/27/2023; 17-271572, Exp. 8/1/2023; 17-271747, Exp. 8/3/2023; 17-271808, Exp. 8/6/2023; 17-272023, Exp. 8/9/2023; 17-272203, Exp. 8/13/2023; 17-272718, Exp. 8/21/2023; 17-272797, Exp. 8/22/2023; 17-273157, Exp. 8/29/2023; 17-273507, Exp. 9/4/2023; 17-273766, Exp. 9/7/2023; 17-273862, Exp. 9/10/2023; 17-274052, Exp. 9/12/2023; 17-274208, Exp. 9/14/2023.
Postal code
92126-6322
Report date
Aug 9, 2023
Product type
Drugs
Recall number
D-1043-2023
Classification
Class II
Recalling firm
Central Admixture Pharmacy Services Inc
Product quantity
5,124 syringes
Termination date
Mar 21, 2025
Reason for recall
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Voluntary / mandated
Voluntary: Firm initiated
Product description
fentaNYL, 1250 mcg/25 mL, (50 mcg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-7
Distribution pattern
Nationwide in the USA
Recall initiation date
Jul 17, 2023
Initial firm notification
Letter
Center classification date
Aug 3, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1043-2023, published Aug 9, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls